ADAM SINGER
Hematology & Oncology Physician · TORRANCE, CA
Individual Active NPI 1770014326
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 511 | 59,429 | $8,585,016 | $1,565,976 | $1,242,698 |
| 2023 | 196 | 13,197 | $1,492,474 | $273,607 | $218,129 |
| 2022 | 15 | 86 | $5,940 | $5,694 | $4,541 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 6,120 | $0 | $0 |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 4,880 | $48 | $39 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 470 | $1 | $1 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 450 | $0 | $0 |
| 99215 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 393 | $193 | $148 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 351 | $17 | $14 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 344 | $0 | $0 |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 243 | $8 | $8 |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 176 | $123 | $98 |
| 96375 | Injection of additional new drug or substance into vein | 160 | $17 | $14 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 160 | $138 | $102 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 152 | $72 | $56 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | A160921 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in California
- NPI 1811456163
- NPI 1154641421
- NPI 1043552243
- NPI 1154858694
- NPI 1487647293
- NPI 1518699982
- NPI 1568451417
- NPI 1891157657
See all Hematology & Oncology Physician providers in California →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.